Profund Advisors LLC Amarin Corp Plcuk Transaction History

Profund Advisors LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 09, 2021	SELL	$4.04 - $5.31 $69,176 - $90,923	-17,123 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$3.64 - $7.76 $11,520 - $24,560	-3,165 Reduced 15.6%	17,123 $72,000
Q2 2020 Aug 03, 2020	BUY	$4.78 - $8.26 $17,542 - $30,314	3,670 Added 22.08%	20,288 $140,000
Q1 2020 May 15, 2020	SELL	$4.0 - $21.53 $20,352 - $109,544	-5,088 Reduced 23.44%	16,618 $66,000
Q4 2019 Feb 18, 2020	SELL	$13.94 - $24.12 $122,853 - $212,569	-8,813 Reduced 28.88%	21,706 $465,000
Q3 2019 Nov 12, 2019	SELL	$13.89 - $23.16 $56,546 - $94,284	-4,071 Reduced 11.77%	30,519 $463,000
Q2 2019 Aug 13, 2019	BUY	$16.27 - $20.51 $7,907 - $9,967	486 Added 1.43%	34,590 $671,000
Q1 2019 May 15, 2019	BUY	$12.61 - $22.33 $70,515 - $124,869	5,592 Added 19.61%	34,104 $708,000
Q4 2018 Feb 14, 2019	BUY	$12.41 - $22.98 $353,833 - $655,205	28,512 New	28,512 $388,000

176

65.1M

258K

98K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $222M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of Profund Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Profund Advisors LLC with notifications on news.